Kidney Transplantation in Patients With AA Amyloidosis: Outcomes in a French Multicenter Cohort.
Fiche publication
Date publication
septembre 2023
Journal
American journal of kidney diseases : the official journal of the National Kidney Foundation
Auteurs
Membres identifiés du Cancéropôle Est :
Pr DUCLOUX Didier
Tous les auteurs :
Schwarz C, Georgin-Lavialle S, Lombardi Y, Marion O, Jambon F, Legendre C, Marx D, Levi C, Toure F, Le Quintrec M, Bobot M, Matignon M, Dujardin A, Maanaoui M, Cuozzo S, Jalal-Eddine A, Louis K, Mohamadou I, Brazier F, De Nattes T, Geneste C, Thervet E, Ducloux D, Mayet V, Kormann R, Lanot A, Duveau A, Zaidan M, Mesnard L, Ouali N, Rondeau E, Petit-Hoang C, Audard V, Deshayes A, Moktefi A, Rabant M, Buob D, François H, Luque Y
Lien Pubmed
Résumé
Outcomes of kidney transplantation for patients with renal AA amyloidosis are uncertain, with reports of poor survival and high rates of disease recurrence. However, data are inconclusive and mostly based on studies from the early 2000s and earlier.
Mots clés
AA amyloidosis, Familial Mediterranean Fever (FMF), anti-IL-1, biotherapies, kidney transplantation, survival
Référence
Am J Kidney Dis. 2023 09 21;: